Nykode Therapeutics
NYKD.OL
#9129
Rank
NZ$0.17 B
Marketcap
NZ$0.55
Share price
-1.58%
Change (1 day)
161.48%
Change (1 year)

Quarterly Reports

Thumbnail Nykode Therapeutics Quarterly Report 2025-q4

Quarterly Report 2025-q4

Language: English

View Quarterly Report
Thumbnail Nykode Therapeutics Quarterly Report 2025-q3

Quarterly Report 2025-q3

Language: English

View Quarterly Report
Thumbnail Nykode Therapeutics Quarterly Report 2025-q2

Quarterly Report 2025-q2

Language: English

View Quarterly Report
Thumbnail Nykode Therapeutics Quarterly Report 2025-q1

Quarterly Report 2025-q1

Language: English

View Quarterly Report
Thumbnail Nykode Therapeutics Quarterly Report 2024-q4

Quarterly Report 2024-q4

Language: English

View Quarterly Report
Thumbnail Nykode Therapeutics Quarterly Report 2024-q3

Quarterly Report 2024-q3

Language: English

View Quarterly Report
Thumbnail Nykode Therapeutics Quarterly Report 2024-q2

Quarterly Report 2024-q2

Language: English

View Quarterly Report
Thumbnail Nykode Therapeutics Quarterly Report 2024-q1

Quarterly Report 2024-q1

Language: English

View Quarterly Report
Thumbnail Nykode Therapeutics Quarterly Report 2023-q4

Quarterly Report 2023-q4

Language: English

View Quarterly Report
Thumbnail Nykode Therapeutics Quarterly Report 2023-q3

Quarterly Report 2023-q3

Language: English

View Quarterly Report
Thumbnail Nykode Therapeutics Quarterly Report 2023-q2

Quarterly Report 2023-q2

Language: English

View Quarterly Report
Thumbnail Nykode Therapeutics Quarterly Report 2023-q1

Quarterly Report 2023-q1

Language: English

View Quarterly Report
Thumbnail Nykode Therapeutics Quarterly Report 2022-q4

Quarterly Report 2022-q4

Language: English

View Quarterly Report
Thumbnail Nykode Therapeutics Quarterly Report 2022-q3

Quarterly Report 2022-q3

Language: English

View Quarterly Report
Thumbnail Nykode Therapeutics Quarterly Report 2022-q2

Quarterly Report 2022-q2

Language: English

View Quarterly Report
Thumbnail Nykode Therapeutics Quarterly Report 2022-q1

Quarterly Report 2022-q1

Language: English

View Quarterly Report